- Home
- VNDA vs FNLC Comparison
VNDA vs FNLC Comparison
Compare VNDA & FNLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- FNLC
- Stock Information
- Founded
- VNDA 2002
- FNLC 1864
- Country
- VNDA United States
- FNLC United States
- Employees
- VNDA N/A
- FNLC N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- FNLC Major Banks
- Sector
- VNDA Health Care
- FNLC Finance
- Exchange
- VNDA Nasdaq
- FNLC Nasdaq
- Market Cap
- VNDA 282.8M
- FNLC 284.1M
- IPO Year
- VNDA 2006
- FNLC 1999
- Fundamental
- Price
- VNDA $4.98
- FNLC $24.81
- Analyst Decision
- VNDA Strong Buy
- FNLC
- Analyst Count
- VNDA 2
- FNLC 0
- Target Price
- VNDA $16.50
- FNLC N/A
- AVG Volume (30 Days)
- VNDA 778.6K
- FNLC 18.6K
- Earning Date
- VNDA 05-07-2025
- FNLC 04-16-2025
- Dividend Yield
- VNDA N/A
- FNLC 5.80%
- EPS Growth
- VNDA N/A
- FNLC N/A
- EPS
- VNDA N/A
- FNLC 2.43
- Revenue
- VNDA $198,772,000.00
- FNLC $79,740,000.00
- Revenue This Year
- VNDA $14.36
- FNLC N/A
- Revenue Next Year
- VNDA $44.53
- FNLC N/A
- P/E Ratio
- VNDA N/A
- FNLC $10.21
- Revenue Growth
- VNDA 3.18
- FNLC 0.35
- 52 Week Low
- VNDA $3.71
- FNLC $21.77
- 52 Week High
- VNDA $6.75
- FNLC $31.05
- Technical
- Relative Strength Index (RSI)
- VNDA 58.23
- FNLC 41.38
- Support Level
- VNDA $4.84
- FNLC $24.34
- Resistance Level
- VNDA $5.10
- FNLC $26.38
- Average True Range (ATR)
- VNDA 0.24
- FNLC 0.57
- MACD
- VNDA 0.02
- FNLC -0.09
- Stochastic Oscillator
- VNDA 76.40
- FNLC 23.04
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.